• Helping you understand who owns the world, and how you can invest in it.
  • Follow us

Immunovant, Inc.

Immunovant, Inc.

Public
IMVT
United States
SectorHealthcare
CountryUnited States
Market cap5.74B
A clinical-stage immunometabolic company developing targeted antibody therapies for severe autoimmune diseases.

Where to buy Immunovant, Inc. (IMVT)

IMVT trades on these platforms. Substox may earn a commission if you open an account through one of these links, at no cost to you. It never changes what the data on this page says. Substox is not a licensed financial adviser and this is not investment advice.

Brands & Subsidiaries 1

Similar public companies in Healthcare